Emrah Otan1, Fatih Mehmet Avşar2

1İnönü Üniversitesi Tıp Fakültesi Genel Cerrahi AD, Malatya
2Ankara Numune Eğitim ve Araştırma Hastanesi, Genel Cerrahi Kliniği, Ankara

Keywords: morbid obesity, laparoscopic gastric band with adjustable stoma, bariatric surgery


Background: Obesity is not only a disease itself, but also has a contributing role in the pathogenesis of life threating diseases and metabolic impairments among which steatosis and hyperlipidemia are well known. Therefore, treatment options for obesity are expected to have beneficial effects on comorbidities related with the disease. In our study, we aimed to investigate the effects of Laparoscopic Gastric Band with Adjustable Stoma (LASGB) on serum lipid and transaminase levels.
Patients and Methods: In our study, 38 morbidly obese patients treated with LASGB were involved. Data were collected from preoperative and postopeartive 3rd month body weight and Body Mass Index (BMI) measurements and serum lipid and AST, ALT,ALP,GGT levels.
Results: Postoperative 3rd month triglyceride, AST,ALT,ALP,GGT levels were significantly low when compared with the preoperative results (p< 0,05).
Discussion: LASGB provides remarkable decrease in body weight and BMI levels, besides its positive contribution to reducing the risk of comorbidities related with morbid obesity.